+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Healthcare Contract Manufacturing Market by Service Type (Analytical Testing, Api Manufacturing, Biologics Manufacturing), Product Type (Biologics, Liquid Dosage, Solid Dosage), Molecule Type, Therapeutic Area, End User, Company Size - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666131
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The healthcare contract manufacturing market is experiencing a period of rapid transformation, characterized by shifts in technology, regulatory demands, and new outsourcing models. Senior decision-makers increasingly rely on robust market intelligence to guide strategic investments and operational realignments in this evolving sector.

Market Snapshot: Healthcare Contract Manufacturing Market

The Healthcare Contract Manufacturing Market grew from USD 201.68 billion in 2024 to USD 219.70 billion in 2025. It is expected to continue growing at a CAGR of 8.52%, reaching USD 329.52 billion by 2030. This growth stems from surging demand among pharmaceutical, biotech, and life sciences firms for outsourced expertise, advanced technologies, and cost-optimized production models.

Scope & Segmentation

This report delivers granular insights into the primary segments, regional dynamics, and enabling technologies shaping the healthcare contract manufacturing market. Key segmentation includes:

  • Service Types: Analytical testing, API manufacturing, biologics manufacturing, clinical trial manufacturing, fill-finish, and formulation development.
  • Product Categories: Biologics, liquid dosage (emulsions, solutions, suspensions), solid dosage (capsules, granules, tablets), and sterile injectable formats (prefilled syringes, vials).
  • Molecule Profiles: Biologics, biosimilars, complex peptides, small molecules.
  • Therapeutic Areas: Cardiovascular, central nervous system, infectious diseases, oncology (hematological malignancies, solid tumors).
  • End Users: Biotech companies, contract research organizations, pharmaceutical companies, research institutions.
  • Company Sizes: Large enterprises, mid-sized enterprises, and small enterprises.
  • Geographies: Americas (United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East, and Africa (United Kingdom, Germany, France, multiple additional regions); Asia-Pacific (China, India, Japan, and others).

Advanced digitalization and Industry 4.0 adoption, such as automation, analytics, and AI-powered manufacturing control, are critical enablers within these segments, with notable investments made in biologics, gene therapy, and personalized medicine capabilities across global supply chains.

Key Takeaways for Senior Decision-Makers

  • Partnerships with contract manufacturing organizations expand sponsor access to highly specialized technology and infrastructure, supporting innovation while reducing operational risk.
  • End-to-end service integration across the development continuum is increasingly sought, enabling seamless transitions from clinical development to commercial production.
  • Rising complexity in biologics and advanced therapeutics is driving a need for investment in adaptive manufacturing platforms and flexible batch processing.
  • Market harmonization across regulatory frameworks is strengthening global product quality, while sustainability initiatives continue to enhance stakeholder alignment.
  • Sponsors are shifting resource allocation toward core R&D, relying on trusted manufacturing partners to handle compliance and advanced production tasks.
  • Regional diversification and supply chain resilience are becoming strategic imperatives, with leaders targeting opportunities in fast-growing Asia-Pacific and Latin American markets.

Tariff Impact on Healthcare Contract Manufacturing

Recent tariff measures by United States authorities have raised input costs for imported raw materials and intermediates. Both sponsors and manufacturing firms are responding by reconfiguring supply chains, prioritizing near-shoring and alternative sourcing to contain financial risk. Strategic use of bonded warehouses, procurement contracts, and customs management solutions is mitigating these pressures, underpinning competitive stability as the sector approaches 2025.

Methodology & Data Sources

The research utilizes a structured multi-phase approach, blending secondary intelligence from published industry, regulatory, and scientific sources with primary interviews of senior executives and technical experts. Data triangulation and iterative expert validation ensure the reliability and accuracy of key findings, producing actionable intelligence for senior stakeholders.

Why This Report Matters

  • Enables senior decision-makers to benchmark their contract manufacturing strategies against best-in-class industry practices and competitive developments.
  • Facilitates risk mitigation and resource optimization through insights on regional trends, tariff impacts, and evolving compliance standards.
  • Supports innovation and supply chain continuity planning by highlighting technology adoption and collaborative partnership models across diverse segments.

Conclusion

This analysis distills the strategic, technological, and regulatory levers transforming healthcare contract manufacturing. Leaders equipped with these insights can anticipate market shifts, enhance operational efficiency, and capitalize on sustainable growth within a dynamic global ecosystem.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Implementation of continuous manufacturing platforms to accelerate biopharmaceutical production timelines
5.2. Integration of advanced AI-driven process analytics for real-time quality monitoring in biologics manufacturing
5.3. Rising demand for multi-product flexible facilities supporting small batch sterility and fill-finish services
5.4. Strategic partnerships between CDMOs and specialty drug developers for niche oligonucleotide therapies
5.5. Scaling up viral vector manufacturing capabilities to meet growing gene therapy clinical trial needs
5.6. Adopting single-use bioreactors and modular cleanroom solutions to reduce contamination risks and costs
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Healthcare Contract Manufacturing Market, by Service Type
8.1. Introduction
8.2. Analytical Testing
8.2.1. Chemical Testing
8.2.2. Microbiological Testing
8.2.3. Stability Testing
8.3. Api Manufacturing
8.3.1. Biotech API
8.3.2. Synthetic API
8.4. Biologics Manufacturing
8.4.1. Monoclonal Antibodies
8.4.2. Recombinant Proteins
8.4.3. Vaccines
8.5. Clinical Trial Manufacturing
8.5.1. Phase I
8.5.2. Phase II
8.5.3. Phase III
8.6. Fill Finish
8.7. Formulation Development
8.7.1. Liquid Dosage
8.7.2. Semi Solid Dosage
8.7.3. Solid Dosage
9. Healthcare Contract Manufacturing Market, by Product Type
9.1. Introduction
9.2. Biologics
9.3. Liquid Dosage
9.3.1. Emulsions
9.3.2. Solutions
9.3.3. Suspensions
9.4. Solid Dosage
9.4.1. Capsules
9.4.2. Granules
9.4.3. Tablets
9.5. Sterile Injectable
9.5.1. Prefilled Syringes
9.5.2. Vials
10. Healthcare Contract Manufacturing Market, by Molecule Type
10.1. Introduction
10.2. Biologics
10.3. Biosimilars
10.4. Complex Peptides
10.5. Small Molecules
11. Healthcare Contract Manufacturing Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.3. Central Nervous System
11.4. Infectious Disease
11.5. Oncology
11.5.1. Hematological Malignancies
11.5.2. Solid Tumors
12. Healthcare Contract Manufacturing Market, by End User
12.1. Introduction
12.2. Biotech Companies
12.3. Cros
12.4. Pharmaceutical Companies
12.5. Research Institutions
13. Healthcare Contract Manufacturing Market, by Company Size
13.1. Introduction
13.2. Large Enterprises
13.3. Mid-Sized Enterprises
13.4. Small Enterprises
14. Americas Healthcare Contract Manufacturing Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Healthcare Contract Manufacturing Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Healthcare Contract Manufacturing Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Lonza Group AG
17.3.2. Catalent, Inc.
17.3.3. Thermo Fisher Scientific Inc.
17.3.4. WuXi AppTec Co., Ltd.
17.3.5. Samsung Biologics Co., Ltd.
17.3.6. Boehringer Ingelheim International GmbH
17.3.7. Fujifilm Diosynth Biotechnologies U.S.A., Inc.
17.3.8. Recipharm AB
17.3.9. Siegfried Holding AG
17.3.10. Aenova Holding GmbH
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. HEALTHCARE CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. HEALTHCARE CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. HEALTHCARE CONTRACT MANUFACTURING MARKET: RESEARCHAI
FIGURE 28. HEALTHCARE CONTRACT MANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 29. HEALTHCARE CONTRACT MANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 30. HEALTHCARE CONTRACT MANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. HEALTHCARE CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CHEMICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CHEMICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MICROBIOLOGICAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STABILITY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOTECH API, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOTECH API, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SYNTHETIC API, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SYNTHETIC API, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FILL FINISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FILL FINISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SEMI SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SEMI SOLID DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY EMULSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY EMULSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY GRANULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY GRANULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY VIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY VIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPLEX PEPTIDES, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPLEX PEPTIDES, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY HEMATOLOGICAL MALIGNANCIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID TUMORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LARGE ENTERPRISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MID-SIZED ENTERPRISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MID-SIZED ENTERPRISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SMALL ENTERPRISES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SMALL ENTERPRISES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 201. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 204. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 205. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 206. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 207. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 208. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 209. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 210. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 211. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 212. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 213. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 216. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 217. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 218. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 219. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2024 (USD MILLION)
TABLE 220. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2025-2030 (USD MILLION)
TABLE 221. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 222. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 223. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 224. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 225. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 226. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 227. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 230. CANADA HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 232. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 233. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 234. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 235. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 236. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 237. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 238. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 239. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 240. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 241. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 242. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 243. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 244. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 245. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 248. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 249. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2024 (USD MILLION)
TABLE 250. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2025-2030 (USD MILLION)
TABLE 251. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 252. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 253. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 254. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 255. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 256. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 257. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 260. MEXICO HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 263. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2018-2024 (USD MILLION)
TABLE 264. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ANALYTICAL TESTING, 2025-2030 (USD MILLION)
TABLE 265. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 266. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY API MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 267. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 268. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY BIOLOGICS MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 269. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2018-2024 (USD MILLION)
TABLE 270. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MANUFACTURING, 2025-2030 (USD MILLION)
TABLE 271. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 272. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY SOLID DOSAGE, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY STERILE INJECTABLE, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL HEALTHCARE CONTRACT MANUFACTURING MARKET SIZE, BY COMPANY SIZE, 2025-2030 (USD MILLION)
TABLE 291. ARGENTINA HEALTHCARE CONTRA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Healthcare Contract Manufacturing market report include:
  • Lonza Group AG
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • WuXi AppTec Co., Ltd.
  • Samsung Biologics Co., Ltd.
  • Boehringer Ingelheim International GmbH
  • Fujifilm Diosynth Biotechnologies U.S.A., Inc.
  • Recipharm AB
  • Siegfried Holding AG
  • Aenova Holding GmbH

Table Information